SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ZILA--test for oral cancer?
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Andrew Spurlin who wrote (41)6/24/1996 12:10:00 PM
From: Grainne   of 61
 
Andrew, PE ratio isn't what is most important with a development stage biotech company. There are usually NO earnings, and these little companies have huge "burn rates" (how much money they spend each year on research) as well. What you should be more concerned with is whether they have patents firmly protecting the research, where the potential product is in its research (phase 3 is best, this is the last stage before FDA approval), whether indeed the FDA did approve the product, whether any of its products are actually on the market, whether any marketed products are approved for Medicare billing, etc. Zila is actually a pretty good little company by these criteria, because it already sells over-the-counter oral hygiene products, and its oral cancer detector is thought to be the very best, and has a huge potential worldwide market. The investor packet is cool! Good luck!
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News